Drug Screening Market NEWS 2025| Thermo Fisher Scientific Launches Next-Generation High-Throughput Drug Screening Platform in Boston to Accelerate Oncology and Rare Disease Therapeutics

The Global Drug Screening Market is expected to grow at a CAGR of 17.1% during the forecasting period (2024-2031).

The drug screening market involves tools and platforms used to evaluate potential drug candidates for efficacy, toxicity, and safety. It includes high-throughput screening, in vitro assays, and computational methods. Pharmaceutical companies use these screenings to accelerate drug discovery and reduce development costs. Advancements in automation and AI-driven analysis have improved accuracy and efficiency. Growing demand for novel therapeutics is a key driver for this market.

📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Drug Screening Market Landscape:- https://datamintelligence.com/download-sample/drug-screening-market?rk

☛ Drug Screening Market Recent Developments 2025:

United States: Recent Industry Developments

✅ In July 2025, Thermo Fisher Scientific launched a next-generation high-throughput drug screening platform in Boston. The system accelerates compound testing for oncology and rare disease therapeutics, reducing assay time by 40%.

✅ In June 2025, Charles River Laboratories expanded its preclinical drug screening services in San Diego. The facility now integrates AI-driven predictive models for toxicity and efficacy, enhancing early-stage drug discovery.

✅ In May 2025, Q2 Solutions partnered with a biotech consortium to deploy automated cell-based drug screening technologies in Maryland. The initiative focuses on accelerating personalized medicine development and immuno-oncology therapies.

Europe: Recent Industry Developments

✅ In July 2025, Evotec AG inaugurated a new drug screening center in Hamburg. The facility specializes in high-content screening for neurological and metabolic disorders, supporting EU-wide collaborative research projects.

✅ In June 2025, Charles River Laboratories expanded its European operations with an advanced assay development lab in Lyon, France. The lab incorporates CRISPR-based screening to improve target validation in early drug discovery.

✅ In May 2025, Eurofins launched AI-powered in vitro drug screening solutions in the UK. The technology predicts pharmacokinetics and toxicity profiles faster, aiming to reduce attrition rates in clinical trials.

☛ Drug Screening Market Trends:

High-throughput and automated drug screening platforms are replacing manual methods, increasing efficiency and accuracy. AI-based predictive models are being integrated to forecast drug safety and efficacy. Miniaturized organ-on-chip and 3D cell culture technologies are enhancing preclinical screening relevance. Growing adoption of virtual screening and computational chemistry reduces time and cost. Collaborations with biotech and pharma companies are driving market expansion.

Recent Pipelines:

Novel assay kits for oncology, immunology, and infectious diseases are in development. AI-powered screening platforms are being optimized for multi-target drug discovery. Advanced in vitro models like microfluidic chips are being tested for toxicity prediction. Screening platforms for gene and cell therapies are emerging. Companies are developing integrated platforms combining biochemical, cell-based, and computational approaches.

☛ Drug Screening Market Competitve Landscape:

Alere, Thermo Fisher Scientific, Drägerwerk, Labcorp, Quest Diagnostics, Alfa Scientific Designs, Lifeloc, MPD Inc., Orasure, Omega Laboratories.

Research Methodology

We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/drug-screening-market

☛ Segment Covered in the Drug Screening Market:

By Product & Service Type: Analytical Instruments, Rapid Testing Devices, Consumables, Drug Screening Services.

By Sample Type: Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Other Samples.

By End User: Workplace, Criminal Justice Systems and Law Enforcement Agencies, Drug Treatment Centers, Pain Management Centers, Schools and Colleges, Hospitals, Individual Users, Drug Testing Laboratories.

☛ This Report Includes:

✔ Comprehensive go-to-market strategies with actionable insights.

✔ Unbiased evaluation of overall market performance.

✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.

✔ Tailored regional and country-level reports with detailed localized analysis available on request.

✔ Identification of niche segments and high-growth regions presenting strong opportunities.

✔ Accurate regional forecasts using both top-down and bottom-up approaches.

📌 Get Corporate Access to Live Drug Screening Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=drug-screening-market

☛ Regional Analysis for Drug Screening Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

☛ Frequently asked questions:

➠ What is the global sales, production, consumption, import, and export value of the Drug Screening Market?
➠ Who are the key global manufacturers, and what is their operational performance?
➠ What are the major opportunities and threats in the global Drug Screening Market?
➠ Which product types or end-users show the most growth potential and market share?
➠ What challenges and constraints are impacting the Drug Screening Market?
➠ What sales, marketing, and distribution channels are used globally?

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.